Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-29

Clinical Trial Update: Oxaliplatin and 5-FU Based Preoperative Chemoradiation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and 5-fluorouracil-based preoperative chemoradiation for rectal cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-FU (5-fluorouracil)
  • Eloxatin (oxaliplatin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED